This page is not indexed by search engines while we improve data quality.

Rappley Irit patents

Rappley Irit is listed as an inventor on 6 patents in our database. Major assignees and classification codes are summarized below.

Notable patents

Publications ranked by popularity score, then publication date.

Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6- dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
US-2023158009-A1 · May 25, 2023 · US
Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
US-11590117-B2 · Feb 28, 2023 · US
Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
US-2021154182-A1 · May 27, 2021 · US
Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
US-2019175573-A1 · Jun 13, 2019 · US
Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
US-10245258-B2 · Apr 2, 2019 · US
Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
US-2017348298-A1 · Dec 7, 2017 · US

Latest publications not already listed above.

No data yet.

Companies most often associated with this inventor's publications.

Top assignees for this inventor
Assignee	Patents
Celgene Corp	6

Most common classification codes across this inventor's patents.